These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 966631)

  • 1. [Relationships between hemopoiesis and peripheral blood counts in untreated and 32P-treated patients with polycythaemia vera (author's transl)].
    Hauswaldt C; Schröter C
    Klin Wochenschr; 1976 Sep; 54(17):823-6. PubMed ID: 966631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition, clinical features and diagnosis of polycythaemia vera.
    Gilbert HS
    Clin Haematol; 1975 Jun; 4(2):263-90. PubMed ID: 1102188
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 32P treatment for polycythaemia vera on blood lymphocyte subpopulations and their functions.
    Petrini B; Blomgren H; Wasserman J; Svedmyr E; Stedingk LV; Schnell PO
    Eur J Haematol; 1987 Sep; 39(3):221-7. PubMed ID: 3678473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the severity degree in polycythemia vera].
    Herrmann T; Franke WG
    Z Gesamte Inn Med; 1974 Jun; 29(11):446-8. PubMed ID: 4848698
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellularity and cell proliferation rates in human bone marrow. 3. Sudies on bone marrow cellularity and erythrokinetics in primary and secondary polycythaemia.
    Skårberg KO; Cea R; Reizenstein P
    Acta Med Scand; 1974 Apr; 195(4):307-11. PubMed ID: 4595257
    [No Abstract]   [Full Text] [Related]  

  • 6. Present status of 32P-therapy in management of polycythemia vera.
    Meuret G
    Klin Wochenschr; 1975 Jun; 53(12):555-8. PubMed ID: 1195656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-therapy in polycythemia vera.
    Meuret G; Hoffmann G; Gmelin R
    Klin Wochenschr; 1975 Jun; 53(11):519-21. PubMed ID: 807769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Night/day plasma iron metabolism studies in patients with polycythaemia vera (author's transl)].
    Triana YG; Putintseva E; Hernández P; Callejas J; Alvarez ME
    Sangre (Barc); 1981; 26(6):1091-6. PubMed ID: 7200640
    [No Abstract]   [Full Text] [Related]  

  • 12. The 'spent' phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis.
    Najean Y; Arrago JP; Rain JD; Dresch C
    Br J Haematol; 1984 Jan; 56(1):163-70. PubMed ID: 6584168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies of splenic erythropoiesis in polycythaemia vera and myelofibrosis.
    Pettit JE; Lewis SM; Williams ED; Grafton CA; Bowring CS; Glass HI
    Br J Haematol; 1976 Nov; 34(3):465-75. PubMed ID: 990184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent studies on the erythropoietin activity in polycythemia vera].
    Nagy G; Deseö G; Rácz M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):436-44. PubMed ID: 4184469
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation of thrombokinetics to bone marrow megakaryocytes and to the size of the spleen in polycythaemia vera.
    Kutti J; Ridell B; Weinfeld A; Westin J
    Scand J Haematol; 1973; 10(2):88-95. PubMed ID: 4731091
    [No Abstract]   [Full Text] [Related]  

  • 17. Polycythaemia vera: differential diagnosis by ferrokinetic studies and treatment with busulphan (Myleran).
    Brodsky I; Kahn SB; Brady LW
    Br J Haematol; 1968 Apr; 14(4):351-61. PubMed ID: 5643288
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CASE OF POLYCYTHEMIA VERA WITH ABNORMAL PROLIFERATION OF BLOOD PLATELETS].
    ITO M; ARAI H; SARUTA E; KIRIHARA N
    Iryo; 1963 Sep; 17():588-92. PubMed ID: 14092801
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
    Rain JD
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.